Exchange: OTC·Updated 01:39 PM EDT

EGRX Eagle Pharmaceuticals Inc

$0.75
$0.165
(18.03%)
Today
Mkt Cap$9.77M
Vol1,146.00

About EGRX

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
50

Neutral Sentiment

How do you feel about EGRX?

Advertisement|Remove ads.